Yüksel Ürün shared a few must-reads paper on X:
1. Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
Authors: Alwin Krämer, Tilmann Bochtler, Chantal Pauli, Kai-Keen Shiu, Natalie Cook, Juliana Janoski de Menezes, Roberto A Pazo-Cid, Ferran Losa, Debbie GJ Robbrecht, Jiří Tomášek, Cagatay Arslan, Mustafa Özgüroğlu, Michael Stahl, Frédéric Bigot, Sun Young Kim, Yoichi Naito, Antoine Italiano, Nasséra Chalabi, Gonzalo Durán-Pacheco, Chantal Michaud, Jeremy Scarato, Marlene Thomas, Jeffrey S Ross, Holger Moch, Linda Mileshkin.
2. Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults
Authors: Alisa Likhitsup, Vincent L. Chen, Robert J. Fontana.
3. Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical Trial
Authors: Vikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, Prabhat Bhargava, Deepali Naughane, Sharon Flavia Sunn, Sujay Srinivas, Akhil Kapoor, Bal Krishna Mishra, Anuj Gupta, Bipinesh Sansar, Vikash Pal, Aparajita Pandey, Avinash Bonda, Indraja Siripurapu, Vamshi Krishna Muddu, Sadhana Kannan, Deepali Chaugule, Rajshree Patil, Manali Parulekar, Aditya Dhanawat, Mehek Trikha, Jaya Ghosh, Vanita Noronha, Nandini Menon, Vijay Patil, Kumar Prabhash, Ian Olver.
4. Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
Authors: Jean-Yves Blay, Quentin Devin, Florence Duffaud, Maud Toulmonde, Nelly Firmin, Olivier Collard, Emmanuelle Bompas, Benjamin Verret, Isabelle Ray-Coquard, Sebastien Salas, Clemence Henon, Charles Honoré, Mehdi Brahmi, Armelle Dufresne, Marc Pracht, Alice Hervieu, Nicolas Penel, Francois Bertucci, Maria Rios, Esma Saada-Bouzid, Pauline Soibinet, David Perol, Sylvie Chabaud, Antoine Italiano, Axel Le Cesne.
5. Oral Antibiotics and Risk of Serious Cutaneous Adverse Drug Reactions
Authors: Erika Y. Lee, Tara Gomes, Aaron M. Drucker, Nick Daneman, Ayesha Asaf, Fangyun Wu, Vincent Piguet, David N. Juurlink.
Read more post from Yuksel Urun on OncoDaily.
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
